Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Patients with significant pre-existing gastrointestinal conditions should be carefully evaluated by their provider before initiating therapy
Zepbound (weekly injection, weight management) Approved in 2023, the same molecule and doses labelled for weight management, with a later indication for moderate-to-severe obstructive sleep apnoea in adults with obesity
Furthermore, ongoing monitoring allows for adjustments based on patient response
GLP-1 alternatives Mounjaro and Zepbound (tirzepatide) Tirzepatide is the active ingredient in Mounjaro and Zepbound
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
